Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
80 hedge funds and large institutions have $212M invested in Calithera Biosciences, Inc in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 12 closing their positions.
41% more call options, than puts
Call options by funds: $465K | Put options by funds: $330K
15% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 26
8% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 12
2% less funds holding
Funds holding: 82 → 80 (-2)
22% less capital invested
Capital invested by funds: $274M → $212M (-$61.6M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$19.2M |
| 2 |
MWNA
Marshall Wace North America
New York
|
+$3.55M |
| 3 |
PC
Polar Capital
London,
United Kingdom
|
+$2.98M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.17M |
| 5 |
State Street
Boston,
Massachusetts
|
+$876K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$7.14M |
| 2 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$3.81M |
| 3 |
Millennium Management
New York
|
-$1.83M |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$1.15M |
| 5 |
Man Group
London,
United Kingdom
|
-$1.08M |
CALA Hedge Fund Activity: Q1 2020 in Review
80 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q1 2020, worth a combined $212M — down 22% from $274M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new CALA positions and 12 closed out — a net gain of 1 holder — while 30 added to existing stakes and 26 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $19.2M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $7.14M sold.
- 80 institutional investors held Calithera Biosciences, Inc (CALA) as of Q1 2020, down from 82 in Q4 2019.
- Funds reported $212M of Calithera Biosciences, Inc stock for Q1 2020, down 22% quarter-over-quarter.
- 13 funds opened new Calithera Biosciences, Inc positions in Q1 2020 and 12 closed out, a net change of +1 holder.
- The largest Calithera Biosciences, Inc buyer in Q1 2020 was Point72 Asset Management, an estimated $19.2M added.
- The largest Calithera Biosciences, Inc seller in Q1 2020 was Adage Capital Partners, an estimated $7.14M sold.
Based on aggregated 13F filings for Q1 2020.